PD-1 Inhibitors Maintenance for cHL Post-autoHCT

Clinical trial NCT06812858 · RECRUITING

Trial details

NCT number: NCT06812858
Sponsor: St. Petersburg State Pavlov Medical University
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Hodgkin Lymphoma

Start date: 2024-01-09
Primary completion: 2029-05-01
Enrollment: 83

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.